Thanks to recent foundation grant funding, a senior research scientist in the Center for Neuropsychology and Neuroscience Research at Kessler Foundation now expands her research targeting greater quality…
TrialSite continues to showcase the El Paso region’s steady rise as a regional research cluster based on the work of local academic medical centers, hospitals…
Eisai announced that the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, has enrolled the first subject in the…
Ionis Pharmaceuticals announced that its partner, Roche, is designing a new Phase 2 trial to evaluate tominersen in Huntington’s disease (HD). In March of 2021,…
Green Valley Pharmaceuticals FDA has approved an Investigational New Drug application (IND) granting initiation of a phase 2 clinical trial of Oligomannate (marketed as GV-971)…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
